PLATINDNSEPlatinum Industries Limited· Chemicals & PetrochemicalsHighNeutral
Announced Tue, 19 Aug, 2025 · 15:50 IST

Platinum Industries Limited has informed the Exchange regarding a press release dated August 19, 2025, titled "Press Release for Unaudited Financial Results for the Quarter ended June 30, 2025.".

Ebitda Margin ExpansionEbitda Margin CompressionResults View source PDFExplain this filing

PLATIND · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-0.2%Reaction day
₹277.70
prior close
₹278.00
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used-0.1%-0.1% vs market
Specialty Chemicals peers, median of 85sector-0.1%-0.0% vs sector

On the reaction day the stock moved 0.1 pts less than Nifty Microcap 250 and in line with its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.3
10m
+0.0
15m
+0.5
30m
+0.0
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-0.2-0.1-0.1-0.1-0.0
Next day
+0.3+0.2+0.1-0.4+0.7
2d
-1.7-0.4-1.3-0.5-1.1
3d
-0.8-0.5-0.3-0.6-0.2
4d
-1.3-2.2+0.9-1.6+0.3
5d
-4.7-2.9-1.8-2.2-2.5
1w
-5.7-1.8-3.8-2.1-3.5
15d
+1.5+0.3+1.3-0.7+2.2
1m
+12.8+1.5+11.3-0.6+13.4
2m
+5.9-0.5+6.4-5.4+11.3
3m
-1.4-1.3-0.0-6.1+4.7
UpDownMarket · Nifty Microcap 250Sector · Specialty Chemicals peers, median of 85Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Platinum Industries reported Q1 FY26 revenue of ₹1,153.82 million, up 12.40% year-on-year and a strong 19.55% sequentially from Q4 FY25, aided by improved capacity utilisation. However, profitability took a hit: EBITDA fell 25.95% YoY to ₹151.57 million with margins contracting 680 bps to 13.14%, and PAT declined 26.28% YoY to ₹130.76 million, largely due to higher employee and operating costs and a shift in product mix. On a sequential basis, the picture is much brighter — EBITDA surged 85.23% QoQ and PAT more than doubled (up 107.29%), with EBITDA margin expanding 466 bps from 8.48% in Q4 FY25. EPS stood at ₹2.32, down 27.27% YoY but up 100% QoQ. The company has started Phase 1 of its Palghar facility (12,000 TPA non-lead CPVC additives) and is preparing a 60,000 TPA REACH-compliant plant in Egypt to capture global opportunities.

Likely market impact

Mixed signals for shareholders: YoY numbers are weak on margins and bottom line, but the strong sequential recovery and explicit margin recovery story are likely to be the focal point for the market. Capacity expansion at Palghar and the Egypt plant could support future growth, though near-term margin pressure from higher costs and product mix remains a watchpoint.